Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2015

View Archived Issues

Evestra receives convertible loan from Gedeon Richter to fund women's health pipeline

Palatin Technologies presents concordance analysis of diagnostic criteria for female sexual disorder

Study tests effects of alprostadil cream on genital blood flow

New softgel capsule technology provides better patient experience

Anti-MAdCAM antibody efficacy results for ulcerative colitis and Crohn's disease

Celimmune founded to develop new therapeutics for celiac and other autoimmune diseases

Eli Lilly and Incyte report phase III data for baricitinib in rheumatoid arthritis

Arrowhead begins phase I trial of ARC-AAT

Rindopepimut receives FDA breakthrough therapy designation in glioblastoma

Novocure enrolls first patient in phase II STELLAR trial

Foundation Medicine and H3 Biomedicine to develop precision therapies for cancer

FDA approves Dymista for use in children with seasonal allergic rhinitis

New guanylyl cyclase activators disclosed by Bayer

Rigel and BMS collaborate on TGF-beta receptor inhibitors for cancer

Gruenenthal divulges novel PDE4B inhibitors

Merck & Co. patents new ROMK channel blockers

Retrospective analysis shows overall survival benefit for ThermoDox in a subgroup of HCC patients

Sunshine Lake Pharma discloses new 5-HT reuptake inhibitors

Boehringer Ingelheim presents new ROR-gamma modulators

PMO targeting Ebola virus VP24 protects nonhuman primates

Takeda to acquire select portfolio from Neutec

FDA approves Novartis's panobinostat for multiple myeloma

ValiRx reports preliminary results from a phase I/II trial of VAL-201 in men with prostate cancer

FDA accepts Taiho's NDA for TAS-102 for refractory metastatic colorectal cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...